Registered number
10558818
I R PHARM LTD
Filleted Accounts
31 January 2026
I R PHARM LTD
Registered number: 10558818
Balance Sheet
as at 31 January 2026
Notes 2026 2025
£ £
Current assets
Debtors 3 100 100
Cash at bank and in hand 58,934 68,188
59,034 68,288
Creditors: amounts falling due within one year 4 (17,009) (28,296)
Net current assets 42,025 39,992
Net assets 42,025 39,992
Capital and reserves
Called up share capital 100 100
Profit and loss account 41,925 39,892
Shareholder's funds 42,025 39,992
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Imran Rabbani
Director
Approved by the board on 28 October 2026
I R PHARM LTD
Notes to the Accounts
for the year ended 31 January 2026
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
2 Employees 2026 2025
Number Number
Average number of persons employed by the company 1 1
3 Debtors 2026 2025
£ £
Other debtors 100 100
4 Creditors: amounts falling due within one year 2026 2025
£ £
Director loan 13,232 24,611
Taxation and social security costs 2,822 2,730
Other creditors 955 955
17,009 28,296
5 Other information
I R PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
7 Haughton Road
Handsworth
Birmingham
West Midlands
B20 3LE
I R PHARM LTD 10558818 false 2025-02-01 2026-01-31 2026-01-31 VT Final Accounts September 2026 Imran Rabbani No description of principal activity 10558818 2024-02-01 2025-01-31 10558818 core:WithinOneYear 2025-01-31 10558818 core:ShareCapital 2025-01-31 10558818 core:RetainedEarningsAccumulatedLosses 2025-01-31 10558818 2025-02-01 2026-01-31 10558818 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 10558818 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 10558818 bus:Director40 2025-02-01 2026-01-31 10558818 countries:England 2025-02-01 2026-01-31 10558818 bus:FRS102 2025-02-01 2026-01-31 10558818 bus:FilletedAccounts 2025-02-01 2026-01-31 10558818 2026-01-31 10558818 core:WithinOneYear 2026-01-31 10558818 core:ShareCapital 2026-01-31 10558818 core:RetainedEarningsAccumulatedLosses 2026-01-31 10558818 2025-01-31 iso4217:GBP xbrli:pure